Brigido Stephen 4

What Happened

• Stephen Brigido, President, Functional Regeneration at Celularity Inc., had 821 restricted stock units (RSUs) vest and convert into Class A common stock on April 13, 2026. The conversion is reported as an exercise/conversion of a derivative (code M) at $0.00.
• To cover tax withholding, 268 of those shares were surrendered (disposed) at $1.28 per share for a withholding value of $343.04 (code F). Net shares retained from this vesting event are 553 shares (821 vested − 268 withheld).
• This was an award/vesting event (routine executive compensation), not an open‑market purchase or sale.

Key Details

• Transaction date: April 13, 2026; Form filed April 15, 2026 (period of report Apr 13, 2026).
• Reported entries: conversion of 821 RSUs to shares (acquired at $0.00); 268 shares withheld for taxes at $1.28/share (≈ $343).
• Source of RSUs: Grant of 3,281 RSUs on April 13, 2022; 25% (821 RSUs) vested on April 13, 2026 (see footnotes F1–F4).
• Shares owned after the transaction are not disclosed in the excerpt of the filing.
• Filing does not indicate a late report; this is a standard RSU vest + share‑withholding for taxes.

Context and plain‑language note:

• RSUs are a form of equity compensation that convert to actual shares when they vest. The share withholding is a common way to satisfy tax obligations and does not represent a market sale by the insider for investment reasons.